These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 11284030

  • 1. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S, Harder L, Gesk S, Schoch R, Jenisch S, Grote W, Siebert R, Schlegelberger B.
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [Abstract] [Full Text] [Related]

  • 2. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 3. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 4. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS, Tang JL, Lee FY, Liu MC, Tsai W, Chen YC, Wang CH, Sheng MC, Lin DT, Lin KH, Tien HF.
    Am J Hematol; 2002 Dec 01; 71(4):291-9. PubMed ID: 12447959
    [Abstract] [Full Text] [Related]

  • 5. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
    Phan TX, Hoang AV, Huynh VM, Nguyen KT, Nguyen TB, Huynh N, Pham QT, Tran VB, Tran VB, Tokunaga K, Sato Y.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):59-68. PubMed ID: 16772122
    [Abstract] [Full Text] [Related]

  • 6. Cytogenetic and molecular mechanisms of resistance to imatinib.
    Hochhaus A.
    Semin Hematol; 2003 Apr 01; 40(2 Suppl 2):69-79. PubMed ID: 12783379
    [Abstract] [Full Text] [Related]

  • 7. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG, Tarpey PS, Nacheva EP.
    Genes Chromosomes Cancer; 2003 Jul 01; 37(3):282-90. PubMed ID: 12759926
    [Abstract] [Full Text] [Related]

  • 8. Differential display analysis of mRNAs in chronic myelogenous leukaemia.
    el-Awady MK, Abdalla NM, Salem AM, Samir S, Nour AM.
    East Mediterr Health J; 2001 Jul 01; 7(4-5):707-15. PubMed ID: 15332769
    [Abstract] [Full Text] [Related]

  • 9. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B, Woroniecka R, Solarska I, Kos K, Pastwińska A, Konopka L, Majewski M.
    Cancer Genet Cytogenet; 2007 Apr 15; 174(2):111-5. PubMed ID: 17452251
    [Abstract] [Full Text] [Related]

  • 10. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA, Hawkins A, Murphy KM, Griffin CA.
    Cancer Genet Cytogenet; 2005 Dec 15; 163(2):164-7. PubMed ID: 16337861
    [Abstract] [Full Text] [Related]

  • 11. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH, Popradi G, Sriharsha L, Kamel-Reid S, Chang H, Messner HA, Lipton JH.
    Cancer; 2008 Aug 15; 113(4):772-81. PubMed ID: 18543309
    [Abstract] [Full Text] [Related]

  • 12. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
    Onozawa M, Fukuhara T, Takahata M, Yamamoto Y, Miyake T, Maekawa I.
    Ann Hematol; 2003 Sep 15; 82(9):593-5. PubMed ID: 12898186
    [Abstract] [Full Text] [Related]

  • 13. The molecular biology of chronic myeloid leukaemia.
    Melo JV.
    Leukemia; 1996 May 15; 10(5):751-6. PubMed ID: 8656667
    [Abstract] [Full Text] [Related]

  • 14. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M, Katayama Y, Okamura A, Yamamoto K, Shimoyama M, Matsui T.
    Cancer Genet Cytogenet; 2007 Nov 15; 179(1):85-7. PubMed ID: 17981222
    [No Abstract] [Full Text] [Related]

  • 15. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W.
    Med Sci Monit; 2002 May 15; 8(5):BR193-7. PubMed ID: 12011769
    [Abstract] [Full Text] [Related]

  • 16. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 May 15; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 17. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P.
    Acta Haematol; 2009 May 15; 122(1):11-6. PubMed ID: 19641300
    [Abstract] [Full Text] [Related]

  • 18. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L, Fajkus J, Polácková K, Fulnecek J, Dvoráková D, Krahulcová E.
    Blood Cells Mol Dis; 2000 Jun 15; 26(3):193-204. PubMed ID: 10950939
    [Abstract] [Full Text] [Related]

  • 19. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
    Zhu B, Shen X, Li C, Lai X, Li Y, Shi K, Feng H, Wang R.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr 15; 17(2):116-8. PubMed ID: 10751535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.